{
}
Versant Ventures has launched Pep2Tango Therapeutics, aiming to create a groundbreaking obesity drug that combines four treatment mechanisms: GLP-1, GIP, amylin, and calcitonin receptors. The startup claims its approach could lead to greater efficacy and reduced muscle loss compared to existing therapies. With significant market potential, Pep2Tango's innovative strategy reflects a shift towards multi-target solutions in obesity treatment.
Eli Lilly and Verge Genomics have made significant strides in developing treatments for amyotrophic lateral sclerosis (ALS) using AI-driven technology. Their collaboration has identified two promising drug targets, with a total investment valued at up to $694 million, aiming to accelerate drug discovery and address critical patient needs.As of November 20, 2024, Eli Lilly's stock (LLY) has rebounded to $744.5, reflecting notable volatility over the past year, with a 52-week range of $561.65 to $972.53. Analysts maintain a "Buy" rating, highlighting the company's strong market position and growth potential.
Eli Lilly"s experimental cholesterol pill, muvalaplin, has shown promising results in a mid-stage trial, significantly reducing levels of lipoprotein(a), a genetic risk factor for heart disease. The highest dose decreased Lp(a) by 70% compared to placebo, with a favorable safety profile. Analysts suggest the drug could become a blockbuster if it proves effective in preventing cardiovascular events in future trials.
The global Hashimoto"s thyroiditis market is projected to grow from $8.3 billion in 2023 to $12.6 billion by 2033, with a CAGR of 4.26%. North America is expected to dominate the market, while Asia-Pacific will experience the fastest growth due to rising healthcare awareness and improved infrastructure. The tablet segment will hold the largest market share, driven by convenience and patient compliance.
Eli Lilly is recommended as a buy, despite its fluctuating stock performance. Coinbase is highlighted as a winner, while IES is noted as a strong infrastructure investment. Marvell Technology is favored, and Apple is advised to be held long-term, with a suggestion to buy on dips. Conversely, Cameco is considered overpriced, and Semtech is viewed as a traditional semiconductor company, with a preference for Texas Instruments.
Robert F. Kennedy Jr."s nomination as secretary of health has caused healthcare stocks to drop, particularly affecting vaccine manufacturers like Moderna and Pfizer. Analysts express uncertainty about his potential impact on the sector, especially regarding vaccine policies and obesity treatments, while noting that large-cap stocks may have room for future growth. Kennedy"s views on drug pricing and oversight of Medicare and Medicaid could also reshape negotiations with pharmaceutical companies.
The global consumer healthcare market is segmented by product types, including OTC pharmaceuticals, personal care products, and dietary supplements, with offline distribution channels expected to dominate. North America is projected to lead the market due to rising awareness of wellness products, while Asia Pacific is anticipated to grow rapidly, driven by increasing disposable incomes and a large elderly population. Key players include Johnson & Johnson, Procter and Gamble, and Pfizer, among others, with ongoing developments enhancing market dynamics.
Eli Lilly has filed a lawsuit against the Biden administration over the 340B drug discount program, seeking to implement a rebate system for hospitals instead of upfront discounts. This follows Johnson & Johnson's similar legal action, as both companies aim to address perceived abuses in the program while ensuring compliance with federal regulations. The lawsuits challenge the Health Resources and Services Administration's guidance, asserting that their proposed rebate models align with the original goals of the 340B program.
Jim Cramer expressed skepticism about the potential impact of Robert F. Kennedy Jr.'s nomination as head of the Department of Health and Human Services on the drug and junk food industries. Despite Kennedy's vaccine skepticism and opposition to processed foods, Cramer believes that government staff and lobbyists will resist significant changes, and that the industries are resilient. He cautioned investors against buying stocks in these sectors, particularly those related to vaccines, during a rate-cutting cycle.
Health stocks fell sharply after President-elect Trump nominated vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. The S&P 500 Health Care Index dropped 1.9%, with major companies like Moderna and Pfizer seeing significant losses. Analysts warn that Kennedy's views could undermine vaccine confidence and impact the biotechnology sector, leading to potential public health risks.
Eli Lilly and Company
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
versant launches pep2tango to develop innovative multi-target obesity drug
AstraZeneca PLC
Novo Nordisk A/S
Eli Lilly and Company
Carlo Rizzuto
Cristina M Rondinone
Soumitra Ghosh
Show more
01:00 21.11.2024
Eli Lilly and Verge Genomics Achieve Breakthroughs in ALS Treatment Development
17:11 20.11.2024
ura and dexcom partner to enhance metabolic health tracking for users
Novartis AG
DexCom, Inc.
Veritone, Inc.
Eli Lilly and Company
Oura
USA
Matt Dolan
Ruth Gimeno
Annika Constantino
David Risinger
Tom Hale
Show more
22:04 19.11.2024
global hashimoto thyroiditis market projected to reach 12.6 billion by 2033
United States Dollar
Amgen Inc.
Merck & Co., Inc.
Novartis AG
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb Company
Takeda Pharmaceuticals Limited Company
Bayer AG
Pfizer Inc.
Roche Holding AG
AbbVie Inc.
AstraZeneca PLC
Eli Lilly and Company
Glaxosmithkline plc
ARG
GBR
FRA
ITA
KOR
ZAF
MEX
USA
BRA
ESP
SAU
CAN
QAT
ARE
JPN
AUS
DEU
CHN
RUS
IND
Pfizer Inc.
AbbVie Inc.
Mylan N.V.
Inc.
Merck & Co
GlaxoSmithKline plc
Show more
04:38 19.11.2024
Cramer endorses Eli Lilly and Coinbase while advising caution on Cameco
Coinbase Global, Inc.
Marvell Technology
Cameco Corporation
Apple Inc.
Semtech Corporation
Eli Lilly and Company
Apple
Marvell Technology
Eli Lilly
Texas Instruments
Jim Cramer
Show more
01:16 19.11.2024
impact of robert f kennedy jr on us healthcare sector uncertainty
Novo Nordisk A/S
Moderna, Inc.
Eli Lilly and Company
Pfizer Inc.
USA
Elon Musk
Vivek Ramaswamy
Donald Trump
Robert Kennedy Jr.
Show more
19:27 18.11.2024
global consumer health market projected to reach over 713 billion by 2033
United States Dollar
Johnson & Johnson
Colgate-Palmolive Company
Bayer AG
Merck & Co., Inc.
Boehringer Ingelheim GmbH
Nestlé S.A.
Mylan N.V.
Reckitt Benckiser Group plc
Novartis International AG
Glaxosmithkline plc
Eli Lilly and Company
Perrigo Company plc
Sanofi
Teva Pharmaceutical Industries Ltd.
Abbott Laboratories
Pfizer Inc.
Procter and Gamble
ESP
IND
QAT
GBR
JPN
KOR
AUS
ARE
CHN
DEU
USA
BRA
RUS
MEX
CAN
ARG
ITA
SAU
ZAF
Brian Johnson
Mylan Nv
Show more
18:35 18.11.2024
eli lilly files lawsuit against government over 340b drug discount program
01:00 18.11.2024
Cramer doubts RFK Jr. will disrupt drug and junk food industries
Moderna, Inc.
General Mills, Inc.
Bristol-Myers Squibb Company
J.M. Smucker de Mexico SA de C.V
Eli Lilly and Company
PepsiCo, Inc.
USA
Jim Cramer
Robert F. Kennedy Jr.
Donald Trump
Show more
01:15 16.11.2024
health stocks decline after trump nominates vaccine skeptic robert f kennedy jr
United States Dollar
Sanofi
Eli Lilly and Company
GSK plc
Novo Nordisk A/S
Roche Holding AG
Pfizer Inc.
USA
GBR
FRA
Brian Abrahams
Robert F. Kennedy Jr.
Michael Yee
Emmanuel Papadakis
Show more
22:25 15.11.2024
Trending
Subcategory
Corporate News
Startups & Entrepreneurship
Industry Trends
Global Trade Developments
Stock Market Updates
Industry Mergers & Acquisitions
Inflation and Monetary Impact
Supply Chain Management
Private Equity Deals
Government Economic Policies
Cryptocurrency Trends
Retail and Consumer Goods
Workplace Trends
Venture Capital Investments
Fintech Startups
CEO Changes
Central Bank Actions
Central Banks and Digital Currencies
Energy Sector Developments
Crypto Policies and Governance
Countries:
Companies:
Apple Inc.
Foxconn Technology Co., Ltd.
NVIDIA Corporation
Nasdaq 100 Jun 25
Tesla, Inc.
Tencent Holdings Ltd
Google Inc.
NIO Inc.
Nikkei 225
Nintendo Co., Ltd.
Grab2Go AS
OLA ELECTRIC MOBILITY LTD
Boeing Co
Airbus SE
Amazon.com, Inc.
Oracle AI USD
AppLovin Corp.
Tesmec S.p.A.
DeepSeek R1 USD
LG Electronics Inc.
Currencies:
United States Dollar
Euro
Indian Rupee
Chinese Yuan
Japanese Yen
United Arab Emirates Dirham
New Taiwan Dollar
Indonesian Rupiah
Saudi Riyal
Offshore Chinese Yuan
Egyptian Pound
Hong Kong Dollar
Malaysian Ringgit
Filipino Peso
West African CFA Franc
South Korean Won
Thai Baht
Mexican Peso
Croatian Kuna
Bahraini Dinar
People: